ropinirole (Requip, Requip XL)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jerry R. Balentine, DO, FACEP
    Jerry R. Balentine, DO, FACEP

    Jerry R. Balentine, DO, FACEP

    Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.

Take the Restless Legs Syndrome Quiz

GENERIC NAME: ropinorole hydrochloride

BRAND NAME: Requip, Requip XL

DRUG CLASS AND MECHANISM: Ropinorole is an anti-Parkinson's medication. Ropinorole works by binding to dopamine receptors in the brain. Ropinorole stimulates the dopamine receptors and improves symptoms of Parkinson's disease. The FDA approved ropinirole in September 1997. It is also a treatment for Restless legs syndrome (RLS ).

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

PREPARATIONS: Tablets (immediate release): 0.25, 0.5, 1, 2, 3, 4, 5 mg. Tablets (extended-release): 2, 4, 6, 8, 12 mg

STORAGE Store ropinorole immediate-release and extended-release tablets between temperatures 15 C and 30 C (59 F and 86 F).

PRESCRIBED FOR: Ropinorole is used for the treatment of signs and symptoms of Parkinson's disease and moderate-to-severe restless leg syndrome (RLS).

DOSING:

Parkinson's disease

Immediate-release tablets: Take 0.25 mg by mouth 3 times a day for week 1, then increase weekly by 0.25 mg 3 times a day if needed. After week 4 doses may be increased by 1.5 mg/day on weekly basis up to a dose of 9 mg/day. If still needed, may increase doses by 3 mg/day on a weekly basis to a total dose of 24 mg/day.

Extended-release tablets: Take 2 mg by mouth once daily for 1 to 2 weeks. Doses can be increased by 2 mg/day at intervals longer than week. Not to exceed 24 mg/day.

Restless Leg Syndrome (RLS)

Immediate release tablets: Take 0.25 mg by mouth 1 to 3 hours before bedtime on day 1 and 2. Starting day 3 to 7, may increase to 0.5 mg by mouth once daily at bedtime. Starting week 2, may increase to 1 mg per day, then increase weekly by 0.5 mg/day to up to 4 mg/day.

DRUG INTERACTIONS: Ropinorole should not be used with phenothiazine, atypical antipsychotics. and metoclopramide (Reglan) because these drugs block dopamine receptors and lead to decreased effectiveness of ropinorole. Examples of phenothiazines include prochlorperazine (Compazine), fluphenazine (Permitil), and trifluoperazine (Stelazine). Examples of atypical antipsychotics include aripiprazole (Abilify), olanzapine (Zyprexa), quetiapine (Seroquel), and rispepridone (Risperdal).

Medically Reviewed by a Doctor on 10/3/2014

Quick GuideRestless Legs Syndrome: Home Remedies for RLS and Better Sleep

Restless Legs Syndrome: Home Remedies for RLS and Better Sleep
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors